Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Welwrd Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Hattar · Pakistan

Hattar-based pharmaceutical manufacturer established in 2005 with quality-management and environmental-management certifications.

Welwrd Pharmaceuticals products in Pakistan

Welwrd Pharmaceuticals has 4 medicine presentations registered in Pakistan under 3 brands, covering 3 generic medicines. Most of its products are in Cross-therapeutic & anti-inflammatory, Anti-infectives and Respiratory & allergy. Its brands with the most registered strengths and packs are L-Predix (Methylprednisolone), Binzet (Terbinafine) and Triptotec Rota (Tiotropium). 4 products have an official DRAP price on MedInfoBase. See all 3 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check25 Sep 2026Latest source-check date across this published portfolio
Latest effective price date11 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
Plot No. 3, Phase I-II, Hattar Industrial Estate, Haripur, Khyber Pakhtunkhwa 22720, Pakistan · 22720
Phone
+92 995 617146
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000574 Welwrd Pharmaceuticals. · Khyber Pakhtunkhwa
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000574 4 linked products · source seen 11 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx53public portfolio records represented
REG53unique registrations represented
IDX4indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+49registry-only registrations
VER49registry-verified exact registrations
PKR4current validated price records
G3generic molecules in indexed catalogue
DF3dosage-form groups
TA3therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage8%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage100%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixWelwrd PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/welwrd-pharmaceuticalsGenerated 11 Nov 2026Cross-therapeutic & anti-inflamma…2 · 50%Anti-infectives1 · 25%Respiratory & allergy1 · 25%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioWelwrd PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/welwrd-pharmaceuticalsGenerated 11 Nov 20264presentationsInjection2 · 50%Capsule1 · 25%Cream1 · 25%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionWelwrd PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/welwrd-pharmaceuticalsGenerated 11 Nov 20264comparable productsBelow peer median2 · 50%Near peer median2 · 50%Above peer median0 · 0%Company median price position-12.1%Lowest-price equivalents3Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsWelwrd PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/welwrd-pharmaceuticalsGenerated 11 Nov 2026M/s. Genix Pharma (Pvt) Ltd.2 shared67% overlapPharmasol (Pvt) Ltd.2 shared67% overlapMacter International Limited2 shared67% overlapHiranis Pharmaceuticals Pvt. Ltd.2 shared67% overlapHorizon Healthcare (pvt.) ltd.2 shared67% overlapBiogen Life Sciences2 shared67% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Formulation footprint

Dosage forms

Injection2 products
Capsule1 products
Cream1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Welwrd Pharmaceuticals is priced against the market

4 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers4Distinct registrations among indexed, published, presentation-validated products only
Verified price observations4
Products with a verified price4
Products with multiple price observations0
Source records with multiple versions3
Latest portfolio source check25 Sep 2026
Latest effective price date11 Aug 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

53 unique registration(s) · 4 indexed presentation(s) · 49 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Azithrocin 250mg CapsuleRegistry verified Azithromycin (as dihydrate) — — — 071654Official source ↗ No indexed price — —
Binzet Terbinafine 1 % Cream 10g 135227 PKR 223.00 PKR 22.30/g 🔒 Pharma Pro
Cef-4 Dry powder injection 1000mgRegistry verified Cefepime (as HCL) with L-Arginine eq. to Cefepime — — — 040371Official source ↗ No indexed price — —
Cef-4 Dry powder injection 500mgRegistry verified Cefepime (as HCL) with L-Arginine eq. to Cefepime — — — 040370Official source ↗ No indexed price — —
Cefowrd 1gm Injection IMRegistry verified Ceftriaxone (as sodium) — — — 069783Official source ↗ No indexed price — —
Cefowrd 250mg Injection IMRegistry verified Ceftriaxone (as sodium) — — — 069781Official source ↗ No indexed price — —
Cefowrd 500mg Injection IMRegistry verified Ceftriaxone (as sodium) — — — 069782Official source ↗ No indexed price — —
Ciprowrd 250mg TabletsRegistry verified Ciprofloxacin(asHCl).....250mg — Tablet — 056372Official source ↗ No indexed price — —
Ciprowrd 500mg TabletsRegistry verified Ciprofloxacin(asHCl).....500mg — Tablet — 056373Official source ↗ No indexed price — —
Ciprowrd TabletRegistry verified Ciprofloxacin (as HCl) — — — 071649Official source ↗ No indexed price — —
Ciprowrd TabletRegistry verified Ciprofloxacin as HCl — — — 071650Official source ↗ No indexed price — —
Ciprowrd Tablet 750mgRegistry verified Ciprofloxacin (as HCl) — — — 108984Official source ↗ No indexed price — —
Clariwel 125mg Dry SuspensionRegistry verified Clarithromycin ...... 125 mg — Suspension — 071657Official source ↗ No indexed price — —
Combmed DPI Capsule 400mcg + 12mcgRegistry verified Budesonide, Formoterol Fumarate Dihydrate — — — 134856Official source ↗ No indexed price — —
Culanz 30mg InjectionRegistry verified Lansoprazole (Lypholized) ...... 30 mg — Injection — 056427Official source ↗ No indexed price — —
E-Soz InjectionRegistry verified Esomeprazole ...... 40 mg — Injection — 064035Official source ↗ No indexed price — —
Esowel-40mg CapsuleRegistry verified Esomeprazole enteric coated pellets eq. to Esomeprazole ...... 40 mg — Capsule — 073212Official source ↗ No indexed price — —
Extum Injection 2.25gmRegistry verified Piperacillin, Tazobactam — — — 123410Official source ↗ No indexed price — —
Extum Injection 4.5gmRegistry verified Piperacillin, Tazobactam — — — 123409Official source ↗ No indexed price — —
Eznokk-N MR Tablet 500mg/20mgRegistry verified Esomeprazole (as Magnesium Trihydrate), Naproxen — — — 135271Official source ↗ No indexed price — —
Fiks 400 mg CapsuleRegistry verified Cefexime ...... 400 mg — Capsule — 053467Official source ↗ No indexed price — —
FloxWel 250mg Dry SuspensionRegistry verified Ciprofloxacin as HCl ...... 250 mg — Suspension — 071656Official source ↗ No indexed price — —
Grucid 20mg CapsuleRegistry verified Omeprazole Pellets equivalent to Omeprazole ...... 20 mg — Capsule — 073211Official source ↗ No indexed price — —
Havogest Tablet 100mgRegistry verified Progesterone (USP) — — — 129087Official source ↗ No indexed price — —
Irowel TabletRegistry verified Iron Polymaltose complex eq to Elemental Iron ...... 100 mg — Tablet — 071653Official source ↗ No indexed price — —
Ketopan Injection 10mgRegistry verified Ketorolac Tromethamol ...... 10 mg — Injection — 068349Official source ↗ No indexed price — —
L-Predix Methylprednisolone 500 mg Injection 1's 135229 PKR 889.00 PKR 889.00/vial/unit 🔒 Pharma Pro
L-Predix Methylprednisolone 1000 mg Injection 1's 135230 PKR 1,481.00 PKR 1,481.00/vial/unit 🔒 Pharma Pro
Levexis 250mg TabletsRegistry verified Levofloxacin hemihydrate eq. to Levofloxacin ...... 250 mg — Tablet — 056374Official source ↗ No indexed price — —
Levexis 500mg TabletsRegistry verified Levofloxacin hemihydrate eq. to Levofloxacin ...... 500 mg — Tablet — 056375Official source ↗ No indexed price — —
Lucatek Cream 1%Registry verified Luliconazole — — — 137509Official source ↗ No indexed price — —
NT-Mather 80mg injectionRegistry verified Artemether ...... 80 mg — Injection — 064036Official source ↗ No indexed price — —
Omarion Tablet 12.5mgRegistry verified Omarigliptin — — — 137375Official source ↗ No indexed price — —
Omarion Tablet 25mgRegistry verified Omarigliptin — — — 137374Official source ↗ No indexed price — —
Orexin 20mg TabletRegistry verified Piroxicam B Cyclodextrin eq to piroxicam ...... 20 mg — Tablet — 071652Official source ↗ No indexed price — —
PNZ injection IVRegistry verified Pantoprazole ( as Sodium Sesquihydrate) ...... 40 mg — Dry powder for injection — 056426Official source ↗ No indexed price — —
Solewel InjectionRegistry verified Sodium chloride ...... 0.9 % — Injection — 060817Official source ↗ No indexed price — —
Sulbotek Rota Capsule 200mcgRegistry verified Salbutamol as Sulphate — — — 137491Official source ↗ No indexed price — —
Tofifa Tablet 5mgRegistry verified Tofacitinib Citrate Eq. to Tofacitinib — — — 135228Official source ↗ No indexed price — —
Trianom Dry Powder 1G InjectionRegistry verified Ceftraixone (as Sodium) — — — 040352Official source ↗ No indexed price — —
Trianom Dry Powder 250mg InjectionRegistry verified Ceftraixone (as Sodium) — — — 040350Official source ↗ No indexed price — —
Trianom Dry Powder500mg InjectionRegistry verified Ceftraixone (as Sodium) — — — 040351Official source ↗ No indexed price — —
Triptotec Rota Tiotropium 18 mcg Capsule 1x6's 137169 PKR 100.00 PKR 16.67/capsule 🔒 Pharma Pro
Welbactum Injection 1gRegistry verified Cefoperazone as sodium, Sulbactum as sodium — — — 041591Official source ↗ No indexed price — —
Welbactum Injection 2gRegistry verified Cefoperazone as sodium, Sulbactum as sodium — — — 041592Official source ↗ No indexed price — —
Welcematol Injection 10mg/mlRegistry verified Paracetamol — — — 110113Official source ↗ No indexed price — —
Welromycin 200mg Dry SuspensionRegistry verified Azithromycin (as dihydrate) ...... 200 mg — Suspension — 071660Official source ↗ No indexed price — —
Weltadal Tablet 5mgRegistry verified Tadalafil — — — 137325Official source ↗ No indexed price — —
Wrdcortis Injection 250mgRegistry verified Hydrocortisone equivalent Hydrocortisone Sodium Succinate (USP) — — — 130867Official source ↗ No indexed price — —
Yampen Injection IV 1gRegistry verified Meropenem (as trihydrate) (Blended with sodium carbonate) — — — 115820Official source ↗ No indexed price — —
A to Z

All 3 Welwrd Pharmaceuticals brands in Pakistan

  • Binzet Terbinafine · 1 % cream
  • L-Predix Methylprednisolone · 1000 mg injection, 500 mg injection
  • Triptotec Rota Tiotropium · 18 mcg capsule
Questions

Welwrd Pharmaceuticals: common questions

How many products does Welwrd Pharmaceuticals have in Pakistan?

Welwrd Pharmaceuticals has 4 registered medicine presentations in Pakistan, sold under 3 brands and covering 3 generic medicines.

What are the main brands of Welwrd Pharmaceuticals?

By number of registered strengths and packs, its largest brands are L-Predix (Methylprednisolone), Binzet (Terbinafine) and Triptotec Rota (Tiotropium). This is not a sales ranking.

Which therapy areas does Welwrd Pharmaceuticals cover?

The most products are in Cross-therapeutic & anti-inflammatory (2), Anti-infectives (1) and Respiratory & allergy (1).

Where can I see Welwrd Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Welwrd Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/welwrd-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9